Ovarian cancer: update on serum biomarkers

A review of the NICE guideline on ovarian cancer has identified new evidence related to the diagnostic accuracy of serum tumour marker HE4 and the ROMA score, resulting in a decision to update advice on what serum tumour marker tests should be carried out routinely to aid diagnosis.

You need to be logged in to read the rest of this story. If you are not already a member, please register with us completely free of charge.
 

Other news

Meeting of Minds

Upcoming Events

Microscience Microscopy Congress 2017 (mmc2017)

Manchester
3-6 July 2017

Pathology Horizons CPD conference

Paradise Palms, Cairns, Australia
10th-12th August

UK NEQAS for Blood Coagulation: Providing an Anticoagulant Service

The Principal York Hotel, Station Road, York YO24 1AA
22 September 2017

IBMS Biomedical Science Congress

ICC, Birmingham
24-27 September 2017

UK NEQAS: Coordinating Point-of-Care Testing

Queen Elizabeth II Conference Centre, Broad Sanctuary, Westminster, London SW1 3EE
20 October 2017

Latest Issue

Pathology In Practice

Pathology In Practice

May 2017

Slides for success in tissue adhesion

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.